Guidelines for ATC classification and DDD assignment - WHOCC

No DDDs are established for local hemostatics classified in this
group.
B02BD Blood coagulation factors
This group comprises all blood coagulation factors, thrombin etc., incl.
preparations for local use, and their combinations. Fibrinogen (factor I),
see - B02BB - Fibrinogen.
The DDDs for the coagulation factor IX (B02BD04 and B02BD09)
are in the lower end of the dose range.
B02BX Other systemic hemostatics
This group comprises systemic hemostatics, which cannot be classified
elsewhere.
B03 ANTIANEMIC PREPARATIONS
B03A IRON PREPARATIONS
This group comprises all plain iron preparations and all combination
products containing more than 30 mg Fe 2+ (or corresponding amounts of
Fe 3+ salts) per defined daily dose (DDD) of the product, regardless of
therapeutic use.
Combined preparations with 30 mg or less Fe 2+ per DDD should be
classified as vitamin preparations in group A11 or as tonics in group
A13. All iron preparations with "iron deficiency" as the main indication
are classified in B03A, regardless of the amount of iron salts.
Only plain preparations should be classified in the groups B03AA,
B03AB and B03AC. Combinations with stabilizing agents (e.g.
ascorbic acid) are allowed at each 5th level. Combinations with e.g.
laxatives are classified at separate 5th levels by using the 50-series.
Other combinations, see B03AD and B03AE.
87